Inflammatory Markers in Tear Fluids Predict Dupilumab-Associated Ocular Surface Disease
The following is a summary of "Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation," published in the February 2024 issue of Allergy & Immunology by Thormann, et al. Dupilumab is commonly used to...